DOW

Dow Inc. 2025 Q1 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2025, for Dow Inc. and its wholly-owned subsidiary, The Dow Chemical Company (TDCC). The report reflects a combined filing due to the parent/subsidiary relationship. Dow operates in a challenging macroeconomic environment characterized by slower GDP growth, high raw material and energy costs, and geopolitical volatility, including trade policy shifts and conflicts in the Middle East and between Russia and Ukraine.

Key Financial Metrics

Liquidity: Total committed and available credit facilities stand at $8.4 billion, all undrawn. Cash and committed liquidity totaled $11.2 billion as of March 31, 2025.

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 3% year-over-year, driven by a 3% decrease in local price and a 1% unfavorable currency impact, partially offset by a 2% volume increase. All operating segments saw sales declines.
• Profitability Reversal: The company reported a net loss of $290 million compared to a net income of $538 million in Q1 2024. This was primarily due to higher restructuring charges, increased cost of sales (93.6% of net sales vs. 88.1% prior year), and lower integrated margins.
• Restructuring Charges: "Restructuring and asset related charges - net" surged to $208 million from $45 million in the prior year. This includes a $207 million charge for the 2025 Restructuring Program (severance for ~1,500 roles) and a $98 million charge related to an arbitration settlement for historical product claims.
• Debt Activity: The company issued $1 billion in senior unsecured notes and used proceeds to retire $943 million of debt, resulting in a $60 million loss on early extinguishment.

Guidance, Outlook, and Risks

• Capital Expenditure Reduction: Dow reduced its full-year 2025 capital expenditure guidance to approximately $2.5 billion (down from $3.5 billion), primarily due to the decision to delay the Path2Zero project in Alberta, Canada, until market conditions improve.
• Cost Savings: The company targets $1 billion in structural cost savings by 2026 through the 2025 Restructuring Program.
• European Asset Review: Dow is expanding a strategic review of select European assets (including facilities in Germany and the UK) due to challenging demand and regulatory environments. Three assets with a combined net book value of ~$275 million are under review for potential idling or shutdown.
• Cash Support: Management expects to deliver approximately $6 billion in near-term cash support via asset sales (up to $3 billion from Gulf Coast infrastructure), legal proceeds (>$1 billion from Nova Chemicals judgment), and CapEx reductions.
• Risks: Key risks include ongoing macroeconomic volatility, potential retaliatory tariffs, supply chain disruptions, and the impact of geopolitical conflicts on energy costs and trade.

Investor Verification Checklist

• Restructuring Execution: Verify the timeline and cash outflow associated with the $207 million severance charge and the $1 billion cost-saving target.
• European Asset Decisions: Monitor the outcome of the strategic review of European assets (Böhlen, Schkopau, Barry) expected by mid-2025 for potential impairment impacts.
• Path2Zero Project Status: Confirm the specific conditions required to resume construction of the delayed Alberta project and its long-term strategic value.
• Legal Proceeds: Track the receipt of the >$1 billion judgment proceeds from Nova Chemicals Corporation expected later in 2025.
• Margin Recovery: Assess whether local pricing power can recover given the 3% price decline and high input costs.